ArticleCell and tissue banking2025
Bioactive human platelet lysate gel for enhanced proliferation of human umbilical cord tissue derived mesenchymal stem cells.
Article in Cell and tissue banking, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mesenchymal Stem cells (MSCs) have a wide range of therapeutic applications due to their self-renewal and multi-lineage differentiation ability; large-scale production of MSCs is possible only with a highly efficient medium, which facilitates increased proliferation of MSCs within a short period. Recently, Human Platelet Lysate (hPL) has emerged as a promising substitute for fetal bovine serum (FBS) for cell expansion. The goal of this study is to optimize a stable gel formulation for the 3D expansion of MSCs using hPL as a matrix material for the improved proliferation of Human Umbilical Cord Tissue derived MSCs (hUCT-MSCs) in comparison to FBS and hPL-supplemented media in 2D culture. To assess the potential benefits of the hPL gel system, in promoting cell proliferation capacity, hUCT-MSCs were cultured on hPL gel coated-dish supplemented with hPL CM, and in FBS CM. Among the varying concentrations, 20% hPL gel was optimized to have more functional stability and shorter gelation time. SEM analysis and gel degradation study at different concentrations revealed the structural integrity and morphology of the gel. Microscopic images and histological staining by H&E were conducted to understand the multi-layered proliferation of hUCT-MSCs in hPL Gel. Flow cytometry analysis reported the expression of positive markers for human umbilical cord MSCs, namely CD 90
Indexed as
Identifiers
40366481What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.